Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Glioblastoma 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Select Advanced Solid Tumors 1 Sarcoma 1 Recurrence 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Glioma 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1

Interventions

Paclitaxel 5 Radiotherapy 3 Fluorouracil 3 Carboplatin 3 nimotuzumab 2 Taxes 2 S 1 (combination) 2 Radiation 2 Oxaliplatin 2 Nivolumab 2 Ferrosoferric Oxide 2 Drug Therapy 2 Cisplatin 2 Cetuximab 2 pembrolizumab 1 entinostat 1 atezolizumab 1 apatinib 1 Watchful Waiting 1 Trastuzumab 1 TH 302 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Proton Therapy 1 Polymerase Chain Reaction 1 Observation 1 Nimodipine 1 Magnetic Resonance Spectroscopy 1 Lubricant Eye Drops 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Esophageal Neoplasms × atezolizumab × Clear all

NCT03818997 2020-02-05

DYNAMIC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡